General Information of Disease (ID: DISMJOSR)

Disease Name Brain and central nervous system tumour
Disease Class 2A00: Brain cancer
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISMJOSR: Brain and central nervous system tumour
ICD Code
ICD-11
ICD-11: 2A00.11
ICD-10
ICD-10: C69-C72, C71

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Tazemetostat DMWP1BH Approved Small molecular drug [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
131 I-omburtamab DM12UX6 Phase 2/3 Antibody [2]
ONC206 DM5VY23 Phase 1 Small molecular drug [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT03275402) 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT04541082) Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms. U.S. National Institutes of Health.